New Addition Brings Mazor Robotics’ Board to Six Members

Israeli company Mazor Robotics Ltd. has appointed Michael Berman to its board of directors effective Feb. 2. Berman’s addition grows the board to 6 members.

Berman is a medical device entrepreneur and investor. He is a co-founder of eight medical device companies and is currently an active board member of several early stage health care companies. Additionally, he was also a co-founder of Velocimed and BridgePoint Medical as well as a board member of Lutonix. From 1995 to 2000 Berman was the President of the cardiology business of Boston Scientific. Berman received his BS and MBA degrees from Cornell University.

“We are excited and honored to welcome Michael to Mazor Robotics’ board of directors,” said Jonathan Adereth, chairman of Mazor’s board of directors. “We believe his experience and successful track record in leading innovative, fast growing medical technology companies will be a valuable asset to Mazor’s board and executive management team at this stage in our company’s development.”

“I have been following Mazor for some time and I am impressed with the performance of the Renaissance system and the company’s success in penetrating the market,” said Berman. “I look forward to leveraging my medical technology expertise as a member of the board of directors by providing counsel and advice to ensure Mazor’s continued success in the robotic surgery market.”

Mazor’s U.S. location is in Orlando, Fla. The company’s robotic system Renaissance focus on spine surgery.